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The magic angle eﬀect increases the MRI signal of healthy tendon tissue and could be used for more detailed evaluation of tendon
structure. Furthermore, it could support the discrimination of hypointense artefacts induced by contrast agents such as
superparamagnetic iron oxide used for cell tracking. However, magic angle MRI of the equine superﬁcial digital ﬂexor tendon
has not been accomplished in vivo in standing low-ﬁeld MRI so far. The aim of this in vivo study was to evaluate the
practicability of this magic angle technique and its beneﬁt for tracking superparamagnetic iron oxide-labelled multipotent
mesenchymal stromal cells. Six horses with induced tendinopathy in their forelimb superﬁcial digital ﬂexor tendons were
injected locally either with superparamagnetic iron oxide-labelled multipotent mesenchymal stromal cells or serum. MRI
included standard and magic angle image series in T1- and T2∗-weighted sequences performed at regular intervals. Image
analysis comprised blinded evaluation and quantitative assessment of signal-to-noise ratio. The magic angle technique enhanced
the tendon signal-to-noise ratio (P < 0:001). Hypointense artefacts were observable in the cell-injected superﬁcial digital ﬂexor
tendons over 24 weeks and artefact signal-to-noise ratio diﬀered signiﬁcantly from tendon signal-to-noise ratio in the magic
angle images (P < 0:001). Magic angle imaging of the equine superﬁcial digital ﬂexor tendon is feasible in standing low-ﬁeld
MRI. The current data demonstrate that the technique improves discrimination of superparamagnetic iron oxide-induced
artefacts from the surrounding tendon tissue.
1. Introduction
In equine practice, tendinopathies most commonly aﬀect the
superﬁcial digital ﬂexor tendon (SDFT) [1, 2] and treatment
is challenging. Consequently, the SDFT is the focus of
research activities aimed at understanding tendon healing
and regenerative therapy options.
Standing low-ﬁeld magnetic resonance imaging (MRI)
oﬀers good opportunities to closely monitor tendon healing,
especially by using T2 and STIR sequences. It also allows lon-
gitudinal cell tracking after injecting superparamagnetic iron
oxide- (SPIO-) labelled cells by the induction of hypointense
artefacts based on inhomogeneities of the local magnetic ﬁeld
in T1- and T2∗-weighted sequences. Tendon signal is depen-
dent on a particular angle θ between the tendon ﬁbres and
the main magnetic ﬁeld B0 [3]. The angle θ = 90° in standard
MRI images leads to a rapid dephasing of the MR signal,
resulting in a hypointense signal of healthy tendon tissue.
The so-called magic angle eﬀect with an angle of approxi-
mately θ = 55° could be useful to improve the value of the
diagnostic procedure. The T2 relaxation time is extended,
and the tendon signal intensity (SI) increases [3, 4]. The
magic angle eﬀect is an artefact and can occur naturally in
tendons and ligaments during MRI which could lead to mis-
diagnosis. But considering special clinical and scientiﬁc prob-
lems, it can provide additional information on the structure
of tendons [5, 6] and could be advantageous for the discrim-
ination of artefacts induced by contrast agents such as SPIO
from the surrounding tissue [7, 8]. Intralesional injection of
multipotent mesenchymal stromal cells (MSC) has been
established with promising results [9–11]. However, little is
known about the behaviour of the cells after injection. There-
fore, MRI tracking would be favourable to monitor the fate of
MSC and the healing process of the tendon lesions. However,
while SPIO-labelled cells can be localised and distinguished
in most tissues, a clear distinction between labelled cells
and healthy tendon tissue is hampered as both display
hypointense signals in standard images. Therefore, it appears
favourable to use the magic angle technique to increase the
tendon signal and support the discrimination of the labelled
MSC after injection into the tendon. This beneﬁcial eﬀect of
the magic angle has already been conﬁrmed ex vivo [12, 13]
and in vivo in rabbits [14], but it has not been performed in
large animal in vivo studies so far [7, 8, 15]. Burk et al. in
2013 have shown that the magic angle eﬀect is feasible in
the SDFT of the midmetacarpal region.
We hypothesised that magic angle images can be
obtained from the equine SDFT in standing low-ﬁeld MRI.
Furthermore, we aimed to evaluate the beneﬁt of the thereby
established technique for cell tracking in tendon lesions,
hypothesising that the magic angle eﬀect (θ = 55°) improves
visualisation of labelled cells inside the tendon tissue com-
pared to standard (θ = 90°) MRI.
2. Materials and Methods
2.1. Tendinopathy Induction. This study was approved by the
local ethics committee (Landesdirektion Leipzig, TVV
34/13), and all ethical guidelines were observed. Six healthy
standardbreds (3 female and 3 male, 3–10 years, 400–
550 kg) were included.
Tendon lesions were induced by the same surgeon in the
midmetacarpal region of the SDFT in both forelimbs under
general anaesthesia. The horses were placed in lateral recum-
bency, and the surgical ﬁelds were prepared aseptically. Via a
2 cm vertical skin incision, an 11-gauge bone marrow aspira-
tion needle (Walter Veterinär-Instrumente e.K., Baruth/-
Mark, Germany) was advanced 2 cm in the proximal
direction into the SDFT. During retraction of the needle,
0.4ml collagenase I (4.8mg/ml; Life Technologies GmbH,
Darmstadt, Germany) was injected into the tendon tissue.
Subsequently, peritendineum and skin were sutured and the
limbs were bandaged. Postoperative management included
standardised pain management with nonsteroidal anti-
inﬂammatory drugs (ﬂunixin meglumine; pre- and 10 h post-
surgery: 1.1mg/kg bwt i.v.; day 1 to day 4 postsurgery:
0.55mg/kg bwt p.o. twice daily; and day 5 to day 6 post sur-
gery: 0.55mg/kg bwt p.o. once daily). The horses were
assessed for pain by a pain scoring system [16] 3 times daily
over a period of 10 days after surgery and, if necessary, addi-
tional analgesics were administered.
2.2. MSC Isolation and Labelling. In the same surgery, subcu-
taneous adipose tissue was collected from the supragluteal
region for the isolation of autologous MSC as described pre-
viously [17, 18]. The plastic-adherent cell fraction was
expanded until passage 2 and was labelled with SPIO (Mol-
day ION Rhodamine B™; iron concentration: 25μg Fe/ml
culture medium, incubation: 20 h; BioPAL, Inc., Worcester,
MA, USA). The MSC were harvested and 10 × 106 cells per
treated tendon were resuspended in 1ml autologous serum
for the intralesional injection. Labelled MSC from each ani-
mal were also used to conﬁrm labelling by Prussian Blue
staining and ﬂow cytometry, trilineage diﬀerentiation poten-
tial, and MSC surface marker expression [19].
2.3. MSC Injection. Three weeks after induction of tendino-
pathy, treatment of the tendon lesions was performed. 10 ×
106 resuspended MSC were injected intralesionally into 1
randomly chosen forelimb of each animal. 1ml autologous
serum was injected as a control into the contralateral fore-
limb. For this purpose, horses were sedated and perineural
anaesthesia of the ulnar nerve and local anaesthesia were per-
formed. The skin was prepared aseptically. A 20-gauge nee-
dle was placed in the tendon lesion under ultrasonographic
monitoring (10MHz linear transducer, LOGIQ 5 Expert;
GE Healthcare, Munich, Germany), and the cell suspension
or serum was injected by the same blinded veterinarian.
From week 2 to week 24 after cell injection, the horses were
subjected to an increasing exercise program [20].
2.4. MRI. For MSC tracking over 24 weeks, the SDFT of both
forelimbs were examined in standing, sedated animals using
an equine-dedicated low-ﬁeld MRI system (0.27 Tesla MRI
unit; Hallmarq Veterinary Imaging, Guildford, Surrey, UK)
as described before [8]. Examinations were performed imme-
diately before and after cell injection as well as 1, 2, 3, 4, 6, 8,
12, and 24 weeks postinjection. Each examination included
transversal T1-weighted and T2∗-weighted gradient echo
MRI sequences (Table 1), both as a standard series as well
as a magic angle series. In the standard series, the whole
injured area was scanned. In the magic angle series of the
MSC-treated forelimb, imaging was limited to the area with
SPIO-induced hypointense artefacts, and in the magic angle
series of the contralateral forelimb, 8 slices were acquired
from the region of the injection.
For the standard series, the poles of the MRI framed the
metacarpus on its medial and lateral side resulting in an angle
of θ = 90° between the SDFT and the static magnetic ﬁeld B0.
For the magic angle series, the SDFT was positioned at an
angle of approximately θ = 55° to the magnetic ﬁeld B0. To
accomplish this, the animal was moved sideways into the
magnet, leaving the poles of the MRI dorsal and palmar to
the metacarpal region, while the carpus was bent and ﬁxed
manually by one person (Figure 1).
2.5. Image Analysis. Image analysis was performed using
Synedra View Personal Version 3.4.0.2 (Synedra Information
Technologies GmbH, Innsbruck, Austria) and Mathematica
10.1 (Wolfram Research, Inc., Champaign, IL, USA). All
T1- and T2∗-weighted standard and magic angle image
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series were randomized, and the presence of a potential
hypointense artefact in each image was determined qualita-
tively in consensus by two blinded observers. First of all,
images displaying potential artefacts were assigned to one
of two categories (category 1: “hypointense area most likely
related to SPIO”; category 2: “questionable hypointense
area”) on the base of position, shape, and intensity (for exam-
ple see Figure 2). Category 1 artefacts generally were charac-
terised by lower SI and a larger area and were often localised
in and around the SDFT. After this, only images with a
potential hypointense artefact (categories 1 and 2) were used
for further analysis. The SI of these artefacts were measured
using a region of interest (circular ROI: 1mm2). Additionally,
the artefact area and its SI were measured based on the whole
Table 1: Settings of MRI sequences.
Sequence TR (ms) TE (ms) FA (°) ST (mm) Gap (mm) FOV (mm2) Matrix
T1w GRE 52 8 50 5 1 171 × 171 256 × 256
T2∗w GRE 68 13 25 5 1 171 × 171 256 × 256
GRE: gradient echo; TR: time to repeat; TE: time to echo; FA: ﬂip angle; ST: slice thickness; FOV: ﬁeld of view.
𝜃
B0
(a)
𝜃
B0
(b)
(c) (d)
Figure 1: Position of the equine limb in the MRI scanner. (a) and (b) show the equine limb positioned between the poles of an equine-
dedicated low-ﬁeld MRI system. In (a), the SDFT of a left forelimb (posterior limb) was positioned in approximately the magic angle
(θ = 55°) to the main magnetic ﬁeld B0. In (b), the SDFT of a right forelimb was positioned in a θ = 90° angle (standard series) to the main
magnetic ﬁeld B0. (c) and (d) show T1-weighted magic angle (c) and standard (d) images of healthy SDFT (arrows) in the midmetacarpal
region. The signal intensity of the SDFT in the magic angle image increases compared to the SDFT in the standard image.
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visible artefact area. In all images assigned to category 1, the
surrounding SDFT SI were measured additionally. In stan-
dard images assigned to category 1, tendon lesion SI were
determined using a region of interest (circular ROI: 1mm2).
This was not possible in magic angle images because of the
diﬃcult delineation between the tendon lesion and the sur-
rounding tendon tissue. All measurements were repeated
three times by a single observer, and mean values were used
for further analysis. Furthermore, the standard deviation
(SD) of the background noise, based on the whole back-
ground areas, was obtained.
For further analysis of all category 1 images, the signal-
to-noise ratios of the diﬀerent structures (SNR = SI/SD
background) and the contrast-to-noise ratios (CNR)
(CNR = ðSI SDFT − SI artefactÞ/SD background) were used.
In contrast, in category 2 images, only the artefact SNR were
calculated for comparison. After all, the data were unblinded
and the selected categorisation was evaluated. The artefact
volumes displayed by all category 1 images within the whole
limb series (V = Σ artefact areas × 6mm; 6mm representing
a slice thickness of 5mm and a gap of 1mm) were calculated.
2.6. Histology. Within the framework of a diﬀerent part of
this study [19], histological sections of the tendons were
obtained from the same horses at week 24 after euthanasia.
Sections from the treated tendon were used to conﬁrm that
SPIO-labelled MSC were still present based on the rhoda-
mine B component of the labelling agent. Brieﬂy, the sections
were subjected to counterstaining of nuclei with DAPI (Carl
Roth GmbH & Co. KG, Karlsruhe, Germany). Other samples
were stained with Prussian Blue with nuclear fast red counter-
staining (Carl Roth GmbH & Co. KG, Karlsruhe, Germany)
to evaluate the presence of ﬁbroblast-like structures. All
images were recorded using a Pannoramic Scan II (3DHIS-
TECH Ltd., Budapest, Hungary). DAPI-stained sections were
evaluated qualitatively by two observers in consensus, and
Prussian Blue-stained sections were evaluated quantitatively
by two blinded, independent observers.
2.7. Statistical Analysis. Statistical analysis was performed
using SPSS® Statistics 22 (IBM, Ehningen, Germany). For
comparisons of SI within the same image, the Wilcoxon test
was used; for comparisons between diﬀerent images, Mann-
Whitney’s U tests were performed. P values < 0.05 were con-
sidered signiﬁcant.
3. Results
3.1. Magic Angle Eﬀect. The magic angle eﬀect was observed
in all examined SDFT in low-ﬁeld MRI. We obtained hyper-
intense signals in the healthy tendon tissue and signiﬁcantly
higher SDFT SNR in magic angle images compared to stan-
dard images in both T1- and T2∗-weighted sequences and
at all time points (P < 0:001) (Figures 3 and 4(a)).
3.2. Artefact Discrimination. Evaluation of the blind review
showed that category 1 artefacts (images: n = 1115) were
all part of the image series obtained from limbs injected with
SPIO-labelled MSC, which demonstrates a correct identiﬁ-
cation of SPIO artefacts (Figure 2). However, among cate-
gory 2 artefacts (images: n = 140), there were also images
obtained from the control limbs (n = 25) or before MSC
injection (n = 10), thus demonstrating that these images
did not reliably display artefacts caused by SPIO-labelled
MSC (Figure 2).
In contrast, artefacts appeared hypointense and with low
SNR in both magic angle and standard category 1 images,
with no signiﬁcant diﬀerences observed at most time points
(Figures 3 and 4(b)). Interestingly, SPIO SNR in the false-
positive category 2 images was not as low as in images of
category 1 (P < 0:001), the diﬀerence being most evident in
T1-weighted magic angle images (Figure 5). However, a
threshold SNR value delimiting SPIO-induced artefacts
could not be deﬁned.
All category 2 images were excluded from the following
analyses. In standard images, when the SPIO artefact was
surrounded by a hyperintense tendon lesion, its borders were
clearly deﬁnable, but when it was localised within healthy
tendon tissue, a clear distinction was only possible in magic
angle images. This observation was reﬂected by the SNR
values obtained from the artefact, the lesion, and the SDFT
(Figure 4(b)). Lesion SNR measured in standard images
was signiﬁcantly higher than artefact SNR in both T1- and
T2∗-weighted sequences and at all time points (P < 0:001).
On the contrary, SDFT SNR in standard images was in a sim-
ilar range as artefact SNR, especially considering the values
obtained from the whole artefact area. However, in the magic
angle images, SDFT SNR was signiﬁcantly higher than arte-
fact SNR in both T1- and T2∗-weighted sequences and at
all time points (P < 0:001). This ﬁnding corresponds to the
comparison of the CNR based on SI SDFT and SI artefact
between magic angle and standard images (Figure 4(c)).
It was signiﬁcantly higher in magic angle images in both
T1- and T2∗-weighted sequences and at all time points
(P < 0:001). Nevertheless, despite these diﬀerences, artefact
volume did not diﬀer signiﬁcantly between magic angle and
90° images (data not shown).
(a) (b)
Figure 2: Categorisation of hypointense artefacts. Sample images
of T1-weighted gradient echo MRI sequences with potential
hypointense artefacts. (a) The arrowhead indicates a region of a
category 2 artefact (“questionable hypointense area”). (b) The
arrows indicate a region of a category 1 artefact (“hypointense
area most likely related to SPIO”).
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3.3. Follow-Up. Category 1 artefacts could be distinguished at
the MSC injection site over the whole follow-up period until
week 24. Artefact SNR constantly remained low, and CNR
correspondingly remained high and was not inﬂuenced by a
decreasing signal during tendon healing over time in T1-
weighted images. In contrast, T2∗-weighted images showed
a decreasing trend in SDFT SNR, which was also evident in
magic angle images and reﬂected by CNR in these images.
Nevertheless, the diﬀerences in CNR between standard and
magic angle images still remained signiﬁcant until week 24
(P < 0:001) (Figure 4).
Evaluation of the histological sections revealed that
SPIO-labelled cells were still present at the lesion site at week
24, suggesting that the artefacts observed in MRI corre-
sponded to labelled MSC (Figure 6).
4. Discussion
The ﬁrst important ﬁnding of this study is that magic angle
images can be obtained from the equine SDFT in standing
low-ﬁeld MRI resulting in images with higher SI in the SDFT.
Therefore, it can be used for preclinical and clinical research
in horses. As demonstrated here, this oﬀers considerable
advantages for cell tracking studies. Moreover, magic angle
images could be used for more detailed diagnostics in tendon
disease [5, 6]. However, while the current data demonstrate
the feasibility of this technique, it should be acknowledged
that the achievable angle between the SDFT and the main
magnetic ﬁeld is limited by the rigid poles of the used low-
ﬁeld MRI scanner and the animal size. Therefore, the stan-
dardisation of image acquisition is challenging and the use
of a wedge was not possible. Furthermore, positioning of
the animal should be performed with caution and there could
be a high risk for injuries for both horse and person. Success
and safety may depend on training and temper of the respec-
tive horse.
The second important ﬁnding of this study is that the
magic angle technique improves the accuracy and reliability
of SPIO-artefact discrimination in the SDFT. So far, the use
of the magic angle eﬀect for cell tracking in vivo had only
been reported in one in vivo study in rabbits [14], in which
comparison with standard images has not been performed.
Although in this study, the artefact volume determined in
the standard image series was similar to those analysed in the
magic angle image series, it should not be assumed that the
cells are located solely within the tendon lesion at all times.
They are likely to be distributed within the healthy tendon
around the lesion and the tendon sheath after being injected
into the lesion [8, 15, 21]. As demonstrated in our study,
SPIO artefacts and healthy tendon tissue display an equally
hypointense signal in standard images. Only the tendon
lesion displays a higher SNR compared to the artefacts, thus
they can be distinguished clearly. However, a reliable identi-
ﬁcation of the artefact area within the whole tendon is nearly
impossible. These issues can be overcome using additional
magic angle images to determine the artefact localisation
more accurately. In magic angle images, only the SPIO arte-
facts display a hypointense signal. Therefore, it is possible
to distinguish them from the surrounding tendon tissue,
which is of particular importance for a detailed tracking of
SPIO-labelled MSC.
Interestingly, a subjective blinded review was demon-
strated to be surprisingly accurate, as no hypointense areas
in control limbs or before MSC injection had been cate-
gorised as “most likely related to SPIO.” In contrast, all
hypointense areas found in control limbs or before cell
injection had been considered as “questionable hypointense
areas,” demonstrating a correct identiﬁcation of potential
false-positive artefacts. Unspeciﬁc artefacts may arise as a
result of high magnetisation at the transition of diﬀerent tis-
sues. However, due to few outlier SNR values in questionable
and SPIO artefacts, it was not possible to deﬁne a ﬁxed
Pre
T1
90°
T1
MA
T2⁎
90°
T2⁎
MA
Post 6 wks 12 wks 24 wks
Figure 3: Exemplary MRI images. Exemplary images of T1- and T2∗-weighted gradient echo MRI sequences before and immediately after as
well as 6, 12, and 24 weeks after cell application at the same level of the limb. The ﬁrst and third rows show standard images (90°), and the
second and fourth rows show the corresponding magic angle (MA) images. The SDFT with its hyperintense lesion is identiﬁed by the
white edging. After injection of labelled cells, they appear as pronounced hypointense artefacts (white arrows). Note that the healthy
tendon tissue (white arrowheads) is diﬃcult to discriminate from the artefact in θ = 90° images but not in the magic angle (MA) images.
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Figure 4: Signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) in standard and magic angle images. (a) Boxplots illustrating
signiﬁcantly higher SDFT SNR in magic angle images (θ = 55°) compared to standard images (θ = 90°) in T1- and T2∗-weighted
sequences and at all time points (P < 0:001). (b) Boxplots displaying the SNR of the artefact ROI, artefact of the whole area, SDFT, and
lesion (only in standard images) in T1-weighted sequences over time. The SNR of hypointense artefacts and SDFT in standard images are
similar, making it challenging to distinguish hypointense artefacts from healthy tendon tissue. In contrast, in the magic angle images,
SDFT SNR was signiﬁcantly higher than artefact SNR (P < 0:001). Lesion SNR in standard images was signiﬁcantly higher than artefact
SNR as well (P < 0:001). (c) Boxplots illustrating the signiﬁcantly higher CNR between SDFT and artefact in magic angle images
compared to standard images in both T1- and T2∗-weighted sequences and at all time points (P < 0:001). Circles and rhombs display
outlier values; wk: week.
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threshold SNR value delimiting true SPIO artefacts in stan-
dard and magic angle MRI images. Possibly, these outlier
values in SPIO artefacts were caused by the partial-volume
eﬀect in MRI images which leads to the interference of signals
and which can therefore increase the SI of especially small
artefact areas. Regarding the lack of signiﬁcant diﬀerences
between artefact volume, it is a surprising ﬁnding and under-
lines that subjective discrimination of artefacts works well in
most cases (as also shown by the subjective artefact categori-
zation). However, the magic angle eﬀect is still very useful in
challenging cases.
To conﬁrm that artefacts seen in MRI correspond to
SPIO-labelled cells, histology can be considered as a gold
standard technique [7, 14, 15]. In the current study, histology
showed that SPIO particles were present and localised in
vital, spindle-shaped cells up to week 24 (Figure 6), as
described in more detail previously [19]. However, while his-
tology remains the most reliable method to validate MRI
results, it is obviously not suitable for longitudinal in vivo
tracking. Therefore, using MRI to obtain standard as well as
magic angle image series, cell tracking was feasible over a
long period of 24 weeks. Yet, it should be acknowledged that
low-ﬁeldMRI, despite using the magic angle technique, is not
suitable to detect small numbers of labelled cells. Using low-
ﬁeld MRI, 100,000 SPIO-labelled MSC were visible in agar
gel but lower concentrations can certainly not be distin-
guished [8]. The cell concentrations in the tendon decrease
over time which is represented by the decreasing artefact
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Figure 5: Diﬀerences in signal-to-noise ratio (SNR) between SPIO or “false” artefacts. Boxplots exhibiting the comparison of artefact SNR in
images categorized as 1 (“hypointense area most likely related to SPIO”=SPIO artefact) and 2 (“questionable hypointense area”=“false”
artefact) in T1-weighted sequences obtained at θ = 90° or magic angle (θ = 55°). It shows that the artefact SNR of the ROI (a) and area (b)
in the potentially false-positive category 2 images was not as low as in the category 1 images (P < 0:001). However, a threshold SNR value
for the discrimination of true SPIO artefacts and other hypointense artefacts was not deﬁnable. Circles and rhombs display outlier values;
diﬀerent assessment time points are summarized.
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volume in MRI and the examination of the histological sec-
tions [7, 19]. Besides this, there were diﬀerent in vivo studies
about longitudinal cell tracking of SPIO-labelled MSC in ten-
dons with a detection period of 8 and 9 weeks but without
further follow-up [7, 8] and in joints with a detection period
of 12 weeks without further follow-up [22].
One limitation of this study was the use of a low-ﬁeld
MRI system, leading to reduced image resolution, relatively
wide slice thickness, and risk of motion artefacts. However,
due to the 1% risk of mortality, general anaesthesia required
for examinations of horses in high-ﬁeld systems is a major
disadvantage [23]. Moreover, the recovery phase may lead
to high strains within the SDFT, leading to a possible nega-
tive eﬀect on tendon healing. Therefore, particularly for stud-
ies involving repeated examinations as well as examining
equine patients, the use of standing low-ﬁeld MRI with a
lower risk for the animals is favourable.
5. Conclusion
In conclusion, in vivo magic angle imaging has not been
described in large animals. The current data show for the ﬁrst
time that the approach is feasible in the horse, which is of
high interest for future in vivo studies. At the same time,
the results demonstrate the advantages of using the technique
in practical implementation for long-term cell tracking.
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